Results lower in peripheral T cells, while the amount of Ezh2 protein in the cytosol remained the same ( Figure 1A ). An additional protein that reacted with the anti-Ezh2 Nonnuclear Localization of Ezh2 in Murine and Human Cells antibody was present in the cytosol of thymocytes and peripheral T cells. However, the presence of this protein In ex vivo isolated thymocytes, the Ezh2 protein concentrated in the nucleus, while a fraction of Ezh2 was in cytosolic extracts derived from the Ezh2-deficient T cells excluded it as an Ezh2 gene product (see Figure  present in the cytosol (Figure 1A) . Compared to the thymocytes, the expression level of nuclear Ezh2 was S1 in the Supplemental Data available with this article online). The T cell antigen receptor (TCR)-mediated ac-S3), cytosolic EED was expressed at the level close to detection limits (data not shown). Nonetheless, immutivation of T cells led to an overall increase in Ezh2 mRNA (data not shown) and protein expression, which noprecipitation of Vav1 coprecipitated with EED ( Figure  1G ). Collectively, these experiments reveal the exiswas accompanied by an increase in the level of cytosolic Ezh2 ( Figure 1A Figures 4C and 4D ). These data demonstrate that cytosolic Ezh2 is sufficient to rescue the formation of This result was consistent with the stability of histone lysine methylation in Ezh2-deficient peripheral T cells dorsal circular ruffles in Ezh2-deficient MEFs and Ezh2 methyltransferase activity is required for PDGF-induc-( Figure 2D ). Maintenance of wild-type H3-K27 trimethylation levels argues against a potential nuclear-mediible actin polymerization in MEFs. phorbol myristate acetate (PMA) in combination with a calcium ionophore (A23187; Figure 6A ).
Incubation of control and Ezh2-deficient T cells with tat-V12-Cdc42 did not cause actin polymerization in the
Similar to Ezh2-deficient T cells, the proliferative responses of the Ezh2-deficient fibroblasts to PDGF was absence of TCR engagement. However, upon anti-CD3 stimulation, tat-V12-Cdc42 restored actin polymerizasignificantly reduced as compared to the wild-type cells ( Figure 6B ). This defect was corrected by retroviral tion in Ezh2-deficient T cells to wild-type levels (Figure 5B) . expression of wild-type and cytosolic Ezh2, but not the cytosolic methyltransferase inactive Ezh2⌬NLSH689A Similar to the Ezh2-deficient T cells, treatment of the Ezh2-deficient fibroblasts with cell-permeable Cdc42 ( Figure 6C) . Notably, treatment of the Ezh2-deficient fibroblasts with serum, which contains a plethora of varirestored PDGF-induced ruffle formation ( Figure 5C ). Moreover, expression of the constitutively active form ous growth-promoting ligands operating via different signaling pathways, induced proliferation at wild-type of RAC1 or oncogenic Vav reconstituted the wild-typelike actin polymerization in the Ezh2-deficient fibrolevels ( Figure 6B ). This result highlights the specific role of Ezh2 and its methyltransferase activity in regulation blasts ( Figure 5C Ezh2 does not regulate Vav1 activity. It is possible that
